Editorial: The long way of biomarkers: From bench to bedside

Intensive Care Medicine

Volumn 36, Issue 4, 2010, Pages 565-566

  Zhang, Haibo ^a,b   Damas, Pierre ^c   Preiser, Jean Charles ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PENTRAXIN 3; PROCALCITONIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CALCITONIN; NERVE PROTEIN; NEURONAL PENTRAXIN; PROTEIN PRECURSOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; CRITICAL ILLNESS; DIAGNOSTIC VALUE; EDITORIAL; FOLLOW UP; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; NONHUMAN; ORGAN INJURY; PATHOGENESIS; PATIENT CARE; PROGNOSIS; PROTEIN EXPRESSION; RELIABILITY; SEPSIS; SURVIVAL; ANIMAL; CHEMISTRY; LUNG LAVAGE; MOUSE; NOTE; PREDICTION AND FORECASTING;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; INFLAMMATION MEDIATORS; MICE; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 77951206452     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1758-z     Document Type: Editorial

References (15)

1. J Silvestre P Povoa L Coelho E Almeida P Moreira A Fernandes R Mealha H Sabino 2009 Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35 909 913 10.1007/s00134-009-1402-y 1:CAS:528: DC%2BD1MXlt1Kjurk%3D 19169668
2. KL Becker R Snider ES Nylen 2008 Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations Crit Care Med 36 941 952 10.1097/CCM.0B013E318165BABB 1:CAS:528:DC%2BD1cXjtlyhsbc%3D 18431284
3. X He B Han M Liu 2007 Long pentraxin 3 in pulmonary infection and acute lung injury Am J Physiol Lung Cell Mol Physiol 292 L1039 L1049 10.1152/ajplung.00490.2006 1:CAS:528:DC%2BD2sXls1yhsr0%3D 17277044 (Pubitemid 47084848)
4. CC dos Santos B Han CF Andrade X Bai S Uhlig R Hubmayr M Tsang M Lodyga S Keshavjee AS Slutsky M Liu 2004 DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch Physiol Genomics 19 331 342 10.1152/physiolgenomics.00153.2004 1:CAS:528:DC%2BD2MXhtVyhtLg%3D 15454581 (Pubitemid 40039938)
5. D Okutani B Han M Mura TK Waddell S Keshavjee M Liu 2007 High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats Am J Physiol Lung Cell Mol Physiol 292 L144 L153 10.1152/ajplung.00002. 2006 1:CAS:528:DC%2BD2sXisFGjtrg%3D 16936248 (Pubitemid 46110451)
6. B Han M Mura CF Andrade D Okutani M Lodyga CC dos Santos S Keshavjee M Matthay M Liu 2005 TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK J Immunol 175 8303 8311 1:CAS:528:DC%2BD2MXht12jt7rO 16339571 (Pubitemid 41798396)
7. T Mauri A Coppadoro G Bellani M Bombino N Patroniti G Peri A Mantovani A Pesenti 2008 Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity Crit Care Med 36 2302 2308 10.1097/CCM.0b013e3181809aaf 1:CAS:528:DC%2BD1cXptFSmsLk%3D 18596636
8. B Muller G Peri A Doni V Torri R Landmann B Bottazzi A Mantovani 2001 Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients Crit Care Med 29 1404 1407 10.1097/00003246-200107000-00017 1:CAS:528:DC%2BD3MXnt1Smt7o%3D 11445697 (Pubitemid 32641804)
9. He X, Han B, Bai X, Zhang Y, Cypel M, Mura M, Keshavjee S, Liu M (2009) PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med. doi: 10.1007/s00134-009-1720-0
10. Mauri T, Bellami G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti A, Mantovani A (2010) Persisting high levels of plasma pentraxin-3 (PTX3) over the first days from severe sepsis and septic shock onset are associated with mortality. Intensive Care Med. doi: 10.1007/s00134-010-1752-5
11. M Savioli M Cugno F Polli P Taccone G Bellani P Spanu A Pesenti G Iapichino L Gattinoni 2009 Tight glycemic control may favor fibrinolysis in patients with sepsis Crit Care Med 37 424 431 10.1097/CCM.0b013e31819542da 1:CAS:528:DC%2BD1MXjs1Kntbk%3D 19114908
12. L Wang JA Bastarache LB Ware 2008 The coagulation cascade in sepsis Curr Pharm Des 14 1860 1869 10.2174/138161208784980581 1:CAS:528:DC%2BD1cXhtVeku7vK 18691097
13. BiomarkersDefinitionsWorking Group 2001 Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89 95 10.1067/mcp.2001.113989 (Pubitemid 32225406)
14. R Latini AP Maggioni G Peri L Gonzini D Lucci P Mocarelli L Vago F Pasqualini S Signorini D Soldateschi L Tarli C Schweiger C Fresco R Cecere G Tognoni A Mantovani 2004 Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction Circulation 110 2349 2354 10.1161/01.CIR.0000145167. 30987.2E 1:CAS:528:DC%2BD2cXosVSlsLY%3D 15477419 (Pubitemid 39407338)
15. M Yoneda T Uchiyama S Kato H Endo K Fujita K Yoneda H Mawatari H Iida H Takahashi H Kirikoshi M Inamori Y Nozaki N Kobayashi K Kubota S Saito S Maeyama M Sagara H Aburatani T Kodama A Nakajima 2008 Plasma pentraxin 3 is a novel marker for nonalcoholic steatohepatitis (NASH) BMC Gastroenterol 8 53 10.1186/1471-230X-8-53 19014569